Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Hemophilia Inhibitor Clinical Trials (INHIBIT) Platform (INHIBIT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02196207
Recruitment Status : Withdrawn (The trial was revised to be two protocols, one Prevention, one Eradication Trials.)
First Posted : July 21, 2014
Last Update Posted : August 20, 2019
Sponsor:
Information provided by (Responsible Party):
Margaret Ragni, University of Pittsburgh

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : July 2027
Estimated Study Completion Date : July 2027